Healthcare Market Research Reports
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
31 Jan 2022  |  Asia Pacific  |  Market Research
Enterprise Imaging Partnerships and Growth Opportunities in Selected Asia-Pacific Countries
New Business Models Overcome Budget Restrictions to Enable Equipment Purchase and Management
In this report, Frost & Sullivan analyzes emerging business models in the medical imaging industry in Asia-Pacific, focusing on India, Australia, Vietnam, Indonesia, and Singapore. Conventional business models that focus on selling products based on specification superiority or unique selling propositions are forecast to slow down. Requirement chan...
$2,450.00 -
16 Apr 2021  |  South Asia, Middle East & North Africa  |  Market Research
Transformative Mega Trends of the Extended Care Market in KSA
Future Growth Potential due to the Adoption of PPP Models
Extended care services emerged from the need to cover long-term healthcare needs for patients who need care, but not hospital beds. The complexity and level of sophistication of care range from basic to very complex, as per the existing medical condition requiring care. The types of care falling under extended care vary from rehabilitation, home ca...
$4,950.00 -
09 Mar 2021  |  South Asia, Middle East & North Africa  |  Market Research
Innovative Public-Private Partnerships Transforming the KSA Healthcare Industry, Outlook 2021
Future Growth Potential Enhanced by Healthcare Infrastructure Upgrade Strategies and Digitization Initiatives
The Kingdom of Saudi Arabia (KSA) is expected to experience economic growth despite oil price complications due to its economic diversion from the oil industry to other industries, with initiatives and strategies that encourage private sector participation. Apart from robust economic growth, the regions business environment will also change radical...
$2,450.00 -
09 Feb 2021  |  South Asia, Middle East & North Africa  |  Market Research
COVID-19 Pandemic Catalyzes the Transformation of the Healthcare Provider Sector in Saudi Arabia
New Spending and the Latest Technology Drive Future Growth Potential
The COVID-19 pandemic has led governments worldwide to implement national lockdowns and social distancing measures to mitigate the virus’ spread. The result is a large-scale drop in business confidence, consumer demand, and industrial production, leading to a global economic recession in 2020. The pandemic has impacted the healthcare sector and i...
$4,950.00 -
12 Nov 2018  |  Asia Pacific  |  Market Research
Analysis of the Singapore Clinical Laboratories Market, Forecast to 2021
Laboratory Automation is Driving the Growth of the Clinical Laboratories Market in the Country
Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...
$1,500.00 -
17 Sep 2018  |  Asia Pacific  |  Market Research
Australian Hospital and Medical Practice Management Solutions Market, Forecast to 2023
Market Growth is Fuelled by Stringent Billing and Reimbursement Regulations
The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At ...
$1,500.00 -
11 Sep 2018  |  Asia Pacific  |  Market Research
Key Medical Imaging Companies in Asia-Pacific, 2018
Local Manufacturers Leverage on Technology, Low Costs, and Core Capabilities to Expand Globally
The Asia-Pacific medical imaging industry is in the growth stage. Both established and new medical imaging manufacturers in the region are constantly focusing on innovating new products, while simultaneously looking at ways to reduce the cost incurred for placing their products. Using these manufacturers as partners or joint venture participants of...
$1,500.00 -
21 Aug 2018  |  Asia Pacific  |  Market Research
Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023
Product Innovation is the Answer for Sustainability in a Dynamic Market
The governments and providers in Asia-Pacific (APAC) are focused on reducing medical expenses while improving population health and well-being. A shortage of medical professionals is seen across multiple specialties in various APAC countries; moreover, clinicians are concentrated in urban areas leading to disproportionate clinician–to-patient rat...
$4,950.00 -
06 Jun 2018  |  Asia Pacific  |  Market Research
Growth Opportunities in the Asia-Pacific Population Health Management Solutions Market, Forecast to 2022
Coordinated Advances in Efficiency and Quality Depend on Collaborative Ecosystems
Population Health Management (PHM) has many connotations ranging from an ideal or a concept to a real market segment. As a concept it refers to the reduction of disease risk and the attached financial burden at a population level. Execution of the concept entails intricate interaction between telehealth technologies, software solutions, and healthc...
$3,000.00 -
16 Apr 2018  |  Asia Pacific  |  Market Research
Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021
Increasing Incidence Rates of Myocardial Infarction and Aging Population in APAC Drive the Troponin Diagnostics Market
Cardiac troponins will continue to remain the gold standard for early diagnosis of acute myocardial infarction (AMI); however, the key challenge to address is the advent of a complementary biomarker to prevent repeat diagnosis. Multiplexing platforms should be harnessed for simultaneous testing of complementary biomarkers such as H-FABP, cardiac my...
$3,000.00